Frontiers in Aging Neuroscience · Nov 16, 2026

Sleep physiology and the biology of brain aging

By Sharom Barbosa-Velásquez, Maite García-Sebastián, Nuole Zhu et al.

Sleep is increasingly linked to cognitive aging and dementia, but the biology is often compressed into a single claim: poor sleep promotes neurodegeneration. That formulation is too broad to be mechanistically useful. Clinical sleep disorders, restricted sleep opportunity, and changes in sleep timing or architecture produce different physiological exposures. Here, we examine how these exposures intersect with brain aging. We follow a common sequence from sleep phenotype and physiological dose to a proposed biological response and its cerebral or clinical consequences. The eight domains considered span protein production and release, fluid transport, vascular and immune injury, metabolic and circadian regulation, and synaptic plasticity. Human experiments show that acute sleep manipulation changes soluble amyloid-beta and tau physiology, whereas many claims about net brain clearance, glial responses, mitochondrial injury, and barrier failure still depend on animal models or indirect human measures. Early degeneration of sleep-regulating networks can itself alter sleep before disease becomes clinically apparent. Disease stage therefore matters when interpreting sleep as a possible contributor, mediator, amplifier, or early marker. We place these relationships within pathways shared by the 14 modifiable dementia risk factors and consider how sex, gender, and structural conditions shape exposure and measurement. The framework identifies the measurements needed to test a specified pathway, including whether treatment changes the intended sleep exposure before a downstream response is assessed. Its central question is which physiological sleep exposure affects which biological pathway, at what stage of brain aging, and with what evidence in humans.

The paperJournal siteMechanisms

AgingResearch.News